News & Articles

New kits support analysis of all organs and species on fresh/fixed frozen and FFPE samples

The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients

A rare lung disease drug is being trialed to help fight COVID-19

Automated “lateral flow” dispensing technology is vital step in rapid point-of-care antibody test production

Olympus imaging systems empower next-generation cancer research at USC’s Ellison Institute

The study is expected to begin enrolling in June with a target of approximately 450 patients globally

Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels

The first 4,000 doses have been delivered for use in the Phase 2/3 clinical trial COV002 by the University of Oxford

First patients are expected to be enrolled shortly and additional European regulatory approvals are in process

The result represents an essential step towards using these molecules for fundamental physics research and beyond

The platform aims to help researchers generate a clearer view of the current state of research and gain invaluable insights

People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus

Cambridge Cognition has secured over $1.5 million in new contracts to support pharmaceutical clients in delivering virtual clinical trials

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

COVID-19 molecular diagnostic and serology antibody testing at core of new suite of services

Ms. Knauer received a certificate signed by the German Federal Minister of Economics and Energy Peter Altmaier